23andMe Holding Co. (ME) Misses Q4 EPS by 3c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/7/2026

1. MRVL
2. ZS
3. PENG
4. STZ
5. CRBU
6. SKYD
7. BBIO
8. OPCH
9. NEOG
10. HALO

Go back to 23andMe Holding Co. (ME) Misses Q4 EPS by 3c

23andMe Reports FY2022 Fourth Quarter and Full Year Financial Results

May 26, 2022 4:05 PM EDT

Achieved FY2022 financial guidanceFourth quarter and full year revenues of $101 million and $272 million representing 14% and 11% increases over prior year, respectivelyNew genomic health services expected in FY2023Webcast today, May 26, 2022, at 4:30 p.m. Eastern Time

SOUTH SAN FRANCISCO, Calif., May 26, 2022 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading consumer genetics and research company with a mission to help people access, understand, and benefit from the human genome, today reported its financial results for the fourth quarter (Q4) and full year of fiscal year 2022 (FY2022), which ended... More